Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report

by Cortellini, Alessio, Verna, Lucilla, Porzio, Giampiero, Bozzetti, Federico, Palumbo, Pierpaolo, Masciocchi, Carlo, Cannita, Katia, Parisi, Alessandro, Brocco, Davide, Tinari, Nicola, Ficorella, Corrado
Published in Thorac Cancer (2019)

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

by Cortellini, Alessio, Bozzetti, Federico, Palumbo, Pierpaolo, Brocco, Davide, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Agostinelli, Veronica, Patruno, Leonardo, Valdesi, Cristina, Mereu, Manuela, Verna, Lucilla, Lanfiuti Baldi, Paola, Venditti, Olga, Cannita, Katia, Masciocchi, Carlo, Barile, Antonio, McQuade, Jennifer Leigh, Ficorella, Corrado, Porzio, Giampiero
Published in Sci Rep (2020)